Incyte to Present at the Fourth Annual JMP Securities Healthcare Focus Conference

• Press Release
• Source: Incyte Corporation
• On 6:00 pm EDT, Wednesday September 30, 2009

WILMINGTON, Del.--(BUSINESS WIRE)--Incyte Corporation (Nasdaq:INCY - News) announced today it will present at the Fourth Annual JMP Securities Healthcare Focus Conference on Monday, October 5, 2009 at 10:30 a.m. ET. Presenting for Incyte Corporation will be Paul Friedman, M.D., president and chief executive officer.

Related Quotes

Symbol	Price	Change
INCY	8.46	+0.74

{"s" : "incy","k" : "c10,l10,p20,t10","o" : "","j" : ""}

The presentation will be webcast live and can be accessed at www.incyte.com under Investor Relations, Events and Webcasts. A replay of the presentation will be available for 90 days. Investors interested in listening to the live webcast should log on before the start time in order to download any software required.

About Incyte

Incyte Corporation is a Wilmington, Delaware-based drug discovery and development company focused on developing proprietary small molecule drugs for oncology, inflammation and diabetes. Incyte’s most advanced compound, INCB18424, is in Phase III development for myelofibrosis. For additional information on Incyte, visit the Company's web site at www.incyte.com.

Incyte Corporation
Pamela M. Murphy
Vice President, Investor Relations/Corporate Communications
302/498-6944